pharmaceutical daily

Novartis announced data that show majority of patients with polycythemia vera treated with Jakavi achieved long-term disease control. The company said…

Novartis reports new analysis showing Xolair® improving quality of life by 78% for chronic spontaneous urticaria patients New analysis from…